P66Shc Deletion Ameliorates Oxidative Stress and Cardiac Dysfunction in Pressure Overload-Induced Heart Failure

被引:11
作者
Wang, Yong [1 ]
Qu, Hua [2 ]
Liu, Jing [1 ]
机构
[1] China Med Univ, Dept Cardiol, Affiliated Hosp 4, 4 Chongshan Rd, Shenyang 110032, Liaoning, Peoples R China
[2] Shenyang Med Coll, Affiliated Hosp 2, Shenyang 110036, Liaoning, Peoples R China
关键词
Pressure overload-induced heart failure; oxidative stress; p66Shc; PDE5; HYPERTROPHY;
D O I
10.1016/j.cardfail.2019.09.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: p66Shc is a redox enzyme that plays an important role in the response of oxidative stress and the p53-dependent apoptosis. The expression level of p66Shc has a negative correlation with the resistance of oxidative stress in vivo and in vitro. We aim to demonstrate the function of p66Shc in pressure overload-induced heart failure. Methods and Results: The pressure overload-induced heart failure was induced in mice by transverse aortic constriction (TAC). Cardiac dysfunction was shown by transthoracic echocardiography. Western blot was used to check the protein levels of phosphodiesterase type 5 (PDE5) and ventricular oxidative stress markers. Superoxide dismutase (SOD) mimetic M40401 and PDE5 inhibitor sildenafil were used in the treatment of mice. The deletion of p66Shc attenuated cardiac dysfunction and oxidative stress in pressure overload-induced heart failure. p66Shc deletion also decreased the expression of ventricular oxidative stress markers and enhanced PKG signaling by promoting the expression of PDE5. M40401 and sildenafil attenuated the TAC-induced cardiac dysfunction and oxidative stress in p66Shc overexpression mice. Conclusions: Our findings suggest that p66Shc participates in the regulation of cardiac dysfunction and oxidative stress in TAC-derived pressure overload-induced heart failure in mice, and SOD and PDE5 are molecules downstream of p66Shc in this regulatory process.
引用
收藏
页码:243 / 253
页数:11
相关论文
共 22 条
  • [1] Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/0968-0004(96)10033-5
  • [2] p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans
    Ciciliot, Stefano
    Albiero, Mattia
    Menegazzo, Lisa
    Poncina, Nicol
    Scattolini, Valentina
    Danesi, Andrea
    Pagnin, Elisa
    Marabita, Manuela
    Blaauw, Bert
    Giorgio, Marco
    Trinei, Mirella
    Foletto, Mirto
    Prevedello, Luca
    Nitti, Donato
    Avogaro, Angelo
    Fadini, Gian Paolo
    [J]. DIABETOLOGIA, 2015, 58 (10) : 2352 - 2360
  • [3] COMPENSATORY AND MALADAPTIVE RESPONSES TO CARDIAC DYSFUNCTION
    FRANCIS, GS
    CHU, CX
    [J]. CURRENT OPINION IN CARDIOLOGY, 1995, 10 (03) : 260 - 267
  • [4] Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis
    Giorgio, M
    Migliaccio, E
    Orsini, F
    Paolucci, D
    Moroni, M
    Contursi, C
    Pelliccia, G
    Luzi, L
    Minucci, S
    Marcaccio, M
    Pinton, P
    Rizzuto, R
    Bernardi, P
    Paolucci, F
    Pelicci, PG
    [J]. CELL, 2005, 122 (02) : 221 - 233
  • [5] Regulation of cardiac hypertrophy by intracellular signalling pathways
    Heineke, Joerg
    Molkentin, Jeffery D.
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2006, 7 (08) : 589 - 600
  • [6] Hill MF, 1996, AM J PATHOL, V148, P291
  • [7] ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the evaluation and management of heart failure)
    Hunt, SA
    Baker, DW
    Chin, MH
    Cinquegrani, MP
    Feldman, AM
    Francis, GS
    Ganiats, TG
    Goldstein, S
    Gregoratos, G
    Jessup, ML
    Noble, RJ
    Packer, M
    Silver, MA
    Stevenson, LW
    Gibbons, RJ
    Antman, EM
    Alpert, JS
    Faxon, DP
    Fuster, V
    Gregoratos, G
    Jacobs, AK
    Hiratzka, LF
    Russell, RO
    Smith, SC
    [J]. CIRCULATION, 2001, 104 (24) : 2996 - 3007
  • [8] Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction?
    Kovacs, A.
    Alogna, A.
    Post, H.
    Hamdani, N.
    [J]. NETHERLANDS HEART JOURNAL, 2016, 24 (04) : 268 - 274
  • [9] Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications
    Kukreja, RC
    Salloum, F
    Das, A
    Ockaili, R
    Yin, C
    Bremer, YA
    Fisher, PW
    Wittkamp, M
    Hawkins, J
    Chou, E
    Kukreja, AK
    Wang, XY
    Marwaha, VR
    Xi, L
    [J]. VASCULAR PHARMACOLOGY, 2005, 42 (5-6) : 219 - 232
  • [10] Oxidative Stress Regulates Left Ventricular PDE5 Expression in the Failing Heart
    Lu, Zhongbing
    Xu, Xin
    Hu, Xinli
    Lee, Sangjin
    Traverse, Jay H.
    Zhu, Guangshuo
    Fassett, John
    Tao, Yi
    Zhang, Ping
    dos Remedios, Cris
    Pritzker, Marc
    Hall, Jennifer L.
    Garry, Daniel J.
    Chen, Yingjie
    [J]. CIRCULATION, 2010, 121 (13) : 1474 - U48